Viewing Study NCT02273050


Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2026-03-02 @ 4:54 PM
Study NCT ID: NCT02273050
Status: COMPLETED
Last Update Posted: 2018-02-05
First Post: 2014-10-22
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin IR Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Drug Naive Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Type 2 Diabetes Mellitus, Dipeptidyl-Peptidase 4 Inhibitors, Saxagliptin, Metformin, Endocrine … View